Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Diamyd Medical AB (publ)
DMYD-BCurrent price
17.18 SEK
+0.64 SEK (+3.87%)
Last closed
16.54 SEK
Company
www.diamyd.com
ISIN
SE0005162880
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
1 659 477 844 SEK
Yield for 12 month
+161.49 %
1Y
3Y
5Y
10Y
15Y
DMYD-B
Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was founded in 1984 and is headquartered in Stockholm, Sweden. Address: Kungsgatan 29, Stockholm, Sweden, 111 56
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
440.25 SEKP/E ratio
–Dividend Yield
–Current Year
+129 015 SEK
Last Year
+541 846 SEK
Current Quarter
+17 863 SEK
Last Quarter
+51 608 SEK
Current Year
-3 552 779 SEK
Last Year
-3 064 522 SEK
Current Quarter
-804 828 SEK
Last Quarter
-13 899 488 SEK
Key Figures DMYD-B
1 year
3 years
5 years
10 years
EBITDA
-140 616 488 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-43.54 %
PEG Ratio
–
Return On Equity TTM
-96.32 %
Wall Street Target Price
440.25 SEK
Revenue TTM
129 011 SEK
Book Value
1.45 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-75.70 %
Dividend Yield
–
Gross Profit TTM
-3 064 517 SEK
Earnings per share
-1.59 SEK
Diluted Eps TTM
-1.59 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-59.40 %
Profit Margin
–
Dividend Analytics DMYD-B
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History DMYD-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation DMYD-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
12460.9574
Price Sales TTM
12863.031
Enterprise Value EBITDA
-7.2438
Price Book MRQ
11.7984
Financials DMYD-B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DMYD-B
For 52 weeks
6.36 SEK
24.81 SEK
50 Day MA
13.65 SEK
Shares Short Prior Month
–
200 Day MA
13.62 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart